Abbott's FreeStyle Libre 3 Plus Now Covered Across Canada

Abbott's (NYSE: ABT) newest sensor-based glucose technology, the FreeStyle Libre 3 Plus* sensor, is now publicly funded in ...
Cantech Letter

Health Canada approves expanded compatibility for mylife Loop with iOS and Abbott’s FreeStyle Libre 3 Plus Sensor

Loop powered by mylife CamAPS FX becomes the first automated insulin delivery system in Canada compatible with two glucose monitoring systems for people living with type 1 diabetes ...
WSB-TV

FDA issues ‘early alert’ over FreeStyle Libre 3 sensors

The Food and Drug Administration issued an “early alert” concerning FreeStyle Libre 3 and FreeStyle Libre Plus sensors used by people who have diabetes. The agency said Abbott Diabetes Care has sent a ...
Monthly Prescribing Reference

New FreeStyle Libre 3 Reader Displays Real-Time Glucose Readings

Credit: Abbott. The FreeStyle Libre 3 reader is a standalone, small handheld device that displays real-time glucose readings. The Food and Drug Administration (FDA) has cleared a standalone reader to ...